Advanced Melanoma Patients with Initial BRAF Therapy Resistance Can Be Treated Again, Study Finds
News
People with advanced and metastatic melanoma who had become resistant to BRAF-targeted therapy were successfully retreated with this therapy after a three-month pause, researchers in Belgium reported. A liquid biopsy tool, Idylla ... Read more